To enhance the efficacy and to mitigate the toxicity issue of LSD1 inhibitors, we screened small molecules for synergistic activity with the LSD1 inhibitor GSK–LSD1 in inducing AML cell differentiation23 (Extended Data Fig. 1a,b). The gene discussed is KDM1A; the disease is acute myeloid leukemia.